The latest health and social care news and a look at research and development into the treatment of common and rare diseases alike. We also look at the vital changes being made to help deliver effective healthcare through the digital transformation within the NHS.
A dangerous hospital superbug, Pseudomonas aeruginosa, can now digest medical plastic like sutures and implants, microbiologists reveal. This alarming ability allows the pathogen to survive longer and form tougher antibiotic-resistant biofilms, posing a significant new threat to patient safety in healthcare settings.
The first wave saw minority ethnicities hit harder than white people, but in the second wave things are improving - with the exception of an "alarming" COVID impact in South Asians, specifically Bangladeshis and Pakistanis.
Israel is currently leading the world in COVID vaccination, with real-world data to suggest that the Pfizer vaccine is working to stop 92% of severe COVID cases.
Cecilia Van Cauwenberghe from Frost & Sullivan’s TechCasting Group, explains how the COVID-19 pandemic is the scenario for testing and demonstrating the successful implementation of diabetes telehealth platforms.
Karina Malhotra, founder and MD, Acumentice, explores how technology is being used to solve the elective care conundrum and to what extent emerging tech can make a credible difference on the front line.
Research found that the supported housing and integrated mental health system could save the NHS £950 million if used as a national strategy for social care.
Early stage data from the vaccine rollout in the UK appears to show that COVID hospitalisation and death are reduced by over 75% in people with the Pfizer vaccine.
Ruth Smith CEO of Active Care Group and its Christchurch Group division discusses the new highly virulent variant of COVID, vaccinations, and infection prevention and control (IPC).
People living with HIV can now get a COVID vaccine without having to tell the doctor their status - right now, the stigma is holding some back from coming forward to get their vaccination.
A new report published in The Lancet investigates why 43% of HIV deaths in 2018 happened in the Black community, with policy solutions for the ongoing HIV epidemic.
The Sinovac COVID vaccine was revealed to be working at 50.4% efficacy by the Butantan Institute last month, but new data suggests that this could actually be 62%.
Four new research studies looking into Long COVID in the community will receive funding worth £18.5 million from UK Research and Innovation (UKRI) and the National Institute for Health Research (NIHR).
The Pfizer and BioNTech vaccine appears to be significantly less efficient against the South African mutation, but can still stop hosts from experiencing severe COVID and dying from the virus.
New data from the REACT study finds that the number of COVID cases in hospitals is higher than it was in April 2020, but that infection rates are substantially decreasing across the country.
